Literature DB >> 2501220

Enhancement of growth of Mycobacterium lepraemurium in macrophages by gamma interferon.

N Mor1, M B Goren, A J Crowle.   

Abstract

Gamma interferon, an immune lymphokine that protects mouse macrophages against infection by several parasites, was ineffective against Mycobacterium lepraemurium. On the contrary, it significantly stimulated multiplication of M. lepraemurium in the macrophages. Simultaneous treatment of macrophages with gamma interferon and interleukin-4 or interleukin-2 or a combination of all three did not enhance the macrophage resistance to infection with M. lepraemurium, but instead stimulated growth of M. lepraemurium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501220      PMCID: PMC313493          DOI: 10.1128/iai.57.8.2586-2587.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.

Authors:  G A Rook; J Steele; M Ainsworth; B R Champion
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

2.  Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.

Authors:  M Belosevic; C E Davis; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

3.  Killing of Mycobacterium microti by immunologically activated macrophages.

Authors:  L Walker; D B Lowrie
Journal:  Nature       Date:  1981-09-03       Impact factor: 49.962

4.  Growth of Mycobacterium lepraemurium in nonstimulated and stimulated mouse peritoneal-derived and bone marrrow-derived macrophages in vitro.

Authors:  J Alexander; C C Smith
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

5.  Discrepancy in assessment of phagosome-lysosome fusion with two lysosomal markers in murine macrophages infected with Candida albicans.

Authors:  N Mor; M B Goren
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

6.  Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages.

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

7.  Cytokine regulation of the intracellular growth of Mycobacterium paratuberculosis in bovine monocytes.

Authors:  B G Zurbrick; D M Follett; C J Czuprynski
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

8.  Immune responses in mice with murine leprosy.

Authors:  W Ptak; J M Gaugas; R J Rees; A C Allison
Journal:  Clin Exp Immunol       Date:  1970-01       Impact factor: 4.330

9.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

Review 10.  Interferon-gamma, the activated macrophage, and host defense against microbial challenge.

Authors:  H W Murray
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

  10 in total
  7 in total

1.  Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).

Authors:  K Sato; T Akaki; H Tomioka
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

2.  Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages.

Authors:  M Denis; E O Gregg
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

3.  Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates.

Authors:  E R Rhoades; I M Orme
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

4.  Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis.

Authors:  T Doi; M Ando; T Akaike; M Suga; K Sato; H Maeda
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Modulation of Mycobacterium lepraemurium growth in murine macrophages: beneficial effect of tumor necrosis factor alpha and granulocyte-macrophage colony-stimulating factor.

Authors:  M Denis
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

6.  Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

7.  Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.